Dedicated to Research Since 1993

IVD MARKET By type (Instruments, Software and Services, Reagents & Kits) By End Users (Hospitals, Point Of Care Testing, Academic and Medical Schools) - Global trends Analysis and Industry Forecast, 2018-2023

 Healthcare and Pharmaceuticals

Report Overview

GLOBAL IVD MARKET was valued at USD 62.01 Billion in the year 2017. Global IVD Market is further estimated to grow at a CAGR of 6.61% from 2018 to reach USD 91.04 Billion. North America region holds the highest market share in 2017 while APAC region is considered as the fastest growing market in the forecasted period. At a country level, the U.S is the biggest market in 2017 and it is projected to grow at a gradual pace in the coming years.

Grifols (Spain), Roche Diagnostics (Switzerland), bioMérieux (France), Abbott Laboratories (U.S.) are some of the key players in the Global IVD market with Roche Diagnostics holding the highest market share. Better global reach, both at production and at an operational level is the main reason for holding this highest market share. Growing research and development expenditures to address changing demand of consumers, new product launches in recent years are some of the key market drivers. Organic growth strategies adopted by most of the top manufacturers in recent years is also provided comprehensive market opportunities for the various stakeholder.


            Growing awareness of self-care medicines

            Growing infectious disease market and adoption of point-of-care testing


            Lack of regulatory standards

            Rising cost of better healthcare facilities


            Increasing significance of diagnostics in improving healthcare quality

            Growing R&D investments.


            Intense competition and declining healthcare reimbursement

The report is segmented as, by type, by technology, by end users, and by region. The reagents and kits segment by type is likely to hold the largest market share during the forecast period. The growth can be attributed to the increasing number of blood donations, rising incidence of infectious diseases, and increasing capacity (disposable income) with a wide range of available reagents and kits. On the other hand, hospitals by users are expected to grow at the highest CAGR during the year 2018-2023 as increasing number of diagnostics tests carried out in hospitals.

By Type                        


Software and Services               

Reagents & Kits                                                 

By Technique                          


Blood testing                 

Molecular diagnostics

Tissue diagnostics

Clinical chemistry          

Other IVD techniques    

By Users                                 


Point Of Care Testing

Academic and Medical Schools


By Region

North America




Key Players

1. Abbott Laboratories (U.S.)                   

2. Beckman Coulter Inc. (U.S.)               

3. Biomérieux SA (France)         

4. Grifols SA (Spain)      

5. F.Hoffmann-La Roche AG (U.S.)                     

6. Becton, Dickinson, and Company (U.S.)            

7. Qiagen Netherlands (includes Digene) (Netherlands)                 

8. Danaher Corporation (Beckman Coulter) Lab 21 (US)               

9. Siemens AG (Germany)

10. Johnson & Johnson (U.S.)     

(A brief overview of another 13 companies is also provided)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1. Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2. Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3. To avoid bias, we filter the collected data collected from authenticated sources.
  4. GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5. Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6. Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

    Key Data from Secondary Research

       2.1.2. Primary Research

    Key Data from Primary Research

    Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottoms-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. IVD Market by type                         

6.1 Introduction            

6.2 Instruments            

6.3 Software and Services                     

6.4 Reagents & Kits

7. IVD Market by Technique                            

7.1 immunodiagnostics              

7.2 Blood testing                       

7.3 Molecular diagnostics

7.4 Tissue diagnostics

7.5 Clinical chemistry     

7.6 Other IVD techniques

8. Molecular Diagnostics Market by End Users                                   

8.1 Hospitals                 

8.2 Point Of Care Testing

8.3 Academic and Medical Schools

8.4 Others

9. Geographical Analysis

9.1. Introduction

9.2. North America

       9.2.1. U.S.

       9.2.2. Canada

       9.2.3. Mexico

9.3. Europe

       9.3.1. Germany

       9.3.2. France

       9.3.3. U.K.

       9.3.4. RoE

9.4. Asia Pacific

       9.4.1. China

       9.4.2. Japan

       9.4.3. India

       9.4.4. RoAPAC

9.5. RoW

       9.5.1. Latin America



    Rest of Latin America

       9.5.2. Middle East and Africa

10. Company Profile                                 

(Business Overview, Patents & Standards, Financial Overview*, Product Portfolio, Recent Developments)                             

10.1 Abbott Laboratories (U.S.)               

10.2 Beckman Coulter Inc. (U.S.)           

10.3 Biomérieux SA (France)      

10.4 Grifols SA (Spain)  

10.5 F. Hoffmann-La Roche AG (U.S.)                  

10.6 Becton, Dickinson and Company (U.S.)        

10.7 Qiagen Netherlands (includes Digene) (Netherlands) 

10.8 Danaher Corporation (Beckman Coulter) Lab 21 (U.S.)          

10.9 Siemens AG (Germany)

10.10 Johnson & Johnson (U.S.)              

(A brief overview of another 13 companies is also provided)

*Details Might Not Be Captured in Case of Unlisted Companies

11. Competitive Analysis

11.1. Introduction

11.2. Market Positioning of Key Players

11.3 Competitive Strategies Adopted by Leading Players

        11.3.1. Investments & Expansions

        11.3.2. New Product Launches

        11.3.3. Mergers & Acquisitions

        11.3.4. Agreements, Joint Ventures, and Partnerships

12. Appendix

12.1. Questionnaire

12.2. Available Customizations 

12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)


No Content Available.